Parabolic Drugs - Quarterly Results
14th Feb 2019

The Sales for the quarter ended December 2018 of Rs. 2.60 million declined by -98.41% from Rs. 163.90 millions.The Net Loss for the quarter ended December 2018 is Rs. -70.90 millions as compared to Net Loss of Rs. -154.80 millions of corresponding quarter ended December 2017 Operating profit Margin for the quarter ended December 2018 improved to -20.00% as compared to -45.40% of corresponding quarter ended December 2017



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201812 201712 % Var 201812 201712 % Var 201803 201703 % Var
Sales 2.60 163.90 -98.41 180.80 563.80 -67.93 726.00 737.20 -1.52
Other Income 0.10 -0.40 -125.00 8.00 40.80 -80.39 41.10 42.50 -3.29
PBIDT -20.00 -45.40 -55.95 -119.80 -88.30 35.67 -119.30 -418.40 -71.49
Interest 0.50 19.00 -97.37 40.10 62.60 -35.94 83.50 99.10 -15.74
PBDT -20.50 -64.40 -68.17 -160.00 -150.80 6.10 -202.80 -517.40 -60.80
Depreciation 51.40 86.50 -40.58 165.40 259.50 -36.26 345.40 534.90 -35.43
PBT -71.90 -150.90 -52.35 -325.40 -410.30 -20.69 -548.20 -1052.30 -47.90
TAX -1.00 3.90 -125.64 -5.90 12.90 -145.74 17.60 30.50 -42.30
Deferred Tax -1.00 3.90 -125.64 -5.90 12.90 -145.74 17.60 30.50 -42.30
PAT -70.90 -154.80 -54.20 -319.60 -423.20 -24.48 -565.80 -1082.80 -47.75
Equity 618.90 618.90 0.00 618.90 618.90 0.00 618.90 618.90 0.00
PBIDTM(%) -769.23 -27.70 2677.03 -66.26 -15.66 323.08 -16.43 -56.74 -71.04